VLN insider sells 437,470 shares in three transactions

VLN insider sales reported via Form 144.

Rhea-AI Filing Summary

VLN insider sales reported via Form 144. The filing lists sales by Dror Jerushalmi: 12/05/2025 — 42,631 Ordinary shares for $72,760.69; 01/02/2026 — 254,131 Ordinary shares for $463,648.70; 02/02/2026 — 140,708 Ordinary shares for $218,189.22.

The reported transactions show cash proceeds upon exercise of options under an Employee Stock Option Plan and list Oppenheimer & Co. Inc. as broker. The filing documents routine insider dispositions rather than corporate actions.

Insights

Securities Compliance Analyst

Form 144 documents multiple insider dispositions by Dror Jerushalmi.

The filing records three sales of Ordinary shares on 12/05/2025, 01/02/2026, and 02/02/2026, with proceeds of $72,760.69, $463,648.70, and $218,189.22 respectively. The securities were sold cash - upon exercise under an Employee Stock Option Plan and routed through Oppenheimer & Co. Inc.

These entries are procedural disclosures of insider sales; there is no indication of corporate-level change or regulatory action in the excerpt. Subsequent filings may provide additional context such as remaining beneficial ownership or any plan-based trading arrangements.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the VLN Form 144 report?

The Form 144 reports three insider sales by Dror Jerushalmi. It lists 42,631, 254,131, and 140,708 Ordinary shares sold on 12/05/2025, 01/02/2026, and 02/02/2026 respectively for stated cash amounts.

Who executed the trades listed in the VLN filing?

The trades were submitted through Oppenheimer & Co. Inc. The filing also indicates the transactions arose from exercises under an Employee Stock Option Plan and were cash proceeds upon exercise.

How much cash did the insider receive in total per the filing?

The filing shows aggregate proceeds of $754,598.61, summing $72,760.69, $463,648.70, and $218,189.22 from the three reported sales on the listed dates.

Does the Form 144 indicate any corporate action by VLN?

No. The Form 144 excerpt lists individual insider dispositions tied to option exercises under an Employee Stock Option Plan and does not disclose corporate transactions, approvals, or policy changes.

Are the sales described as part of a planned trading program?

The excerpt does not state that the sales were made under a trading program. It specifies Cash - Upon Exercise under the Employee Stock Option Plan but does not reference a Rule 10b5-1 plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 08:21 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001965405
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Valens Semiconductor Ltd.
SEC File Number	001-40842
Address of Issuer	8 HANAGAR ST. POB 7152 HOD HASHARON, 4501309 ISRAEL 00000
Phone	972-9-762-6900
Name of Person for Whose Account the Securities are To Be Sold	Jerushalmi Dror
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 broad st. New York NY 10004	10050	14673.00	106342415	02/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	06/01/2017	Employee Stock Option Plan	Issuer			10050	02/18/2026	Cash - Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Dror Jerushalmi 8 HANAGAR ST. POB 7152 HOD HASHARON L3 4501309	Ordinary	12/05/2025	42631	72760.69
Dror Jerushalmi 8 HANAGAR ST. POB 7152 HOD HASHARON L3 4501309	Ordinary	01/02/2026	254131	463648.70
Dror Jerushalmi 8 HANAGAR ST. POB 7152 HOD HASHARON L3 4501309	Ordinary	02/02/2026	140708	218189.22

144: Remarks and Signature

Remarks
Date of Notice	02/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Dror Jerushalmi
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)